insights_auto
Why is TNXP up २.७८%?
Dive Deeperchevron_right
TNXP:NASDAQ
Tonix Pharmaceuticals Holding Corp
US$ २.९६
arrow_upward
+२.७८%(+०.०८०) 1D
नोभेम्बर १७, १०:०७:२९ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNXP...
Open
US$ २.८७
High
US$ २.९८
Low
US$ २.८४
Mkt. cap
५.७५ करोड
Avg. vol.
११.६२ लाख
Volume
५०.१३ हजार
52-wk high
US$ २०.५६
52-wk low
US$ २.८१
EPS
-US$ १२.२३
Beta
१.९०
Shares outstanding
१.९४ करोड
No. of employees
१४२
Open
US$ २.८७
High
US$ २.९८
Low
US$ २.८४
Mkt. cap
५.७५ करोड
Avg. vol.
११.६२ लाख
Volume
५०.१३ हजार
52-wk high
US$ २०.५६
52-wk low
US$ २.८१
EPS
-US$ १२.२३
Beta
१.९०
Shares outstanding
१.९४ करोड
No. of employees
१४२
News stories
From web sources and news partners
Yahoo Finance
·
१ दिन पहिले
TNXP: Tonmya® Launch Continues to Build Momentum; 37% QoQ Growth in Revenue
Yahoo Finance
·
४ दिन पहिले
TNXP 8-K & SEC Filings
Profile
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
About Tonix Pharmaceuticals Holding Corp
CEOSeth Lederman
Employees१४२
Founded२००७
HeadquartersBerkeley Heights, न्यु जर्सी, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Websitetonixpharma.com